Tag: Novo Nordisk A/S
Eli Lilly CFO Anat Ashkenazi on managing soaring demand for GLP-1s
A pharmacist holds boxs of Eli Lilly & Co. Mounjaro brand tirzepatide medication arranged at a pharmacy in Provo, Utah, US, on Monday, Nov. 27, 20 [...]
Ro launches GLP-1 supply tracker to help patients navigate shortages
GLP-1 Supply Tracker from Ro. Courtesy: RoTelehealth company Ro on Wednesday launched a new tracker to help patients find a popular class of weight lo [...]
Hims & Hers weight loss adds compounded GLP-1 injections
Products of Hims & Hers displayed.Hims & HersDigital pharmacy startup Hims & Hers Health is introducing access to compounded GLP-1 weight [...]
Roche weight loss drug shows promising results in early trial
A logo at the Roche Holding AG headquarters in Basel, Switzerland, on Thursday, Feb. 1, 2024.Bloomberg | Getty ImagesRoche on Thursday said its experi [...]
Wegovy patients maintain weight loss for 4 years: Novo Nordisk study
Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. Hollie Adams | ReutersPatients taking Novo Nordisk's obe [...]
Amgen could threaten Novo Nordisk, Eli Lilly weight loss drug dominance
The injectable weight-loss medication Wegovy is available at New City Halstead Pharmacy on April 24, 2024 in Chicago, Illinois.Scott Olson | Getty Ima [...]
Amgen scraps experimental weight loss pill, moves forward with injection
The Amgen logo is displayed outside Amgen headquarters in Thousand Oaks, California, on May 17, 2023.Mario Tama | Getty ImagesAmgen on Thursday said i [...]
Amgen soars on weight loss drug progress, Novo Nordisk, Eli Lilly slide
Amgen's stock rose more than 12% on Friday after the drugmaker teased positive initial data on its experimental weight loss injection. That fueled inv [...]
FTC challenges patents held by drugmakers, including for Ozempic
A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, October 31, 2023. Lee Smith | ReutersThe Federal Trade Commission on [...]
3.6 million Medicare patients could get heart health coverage
More than 3 million people with Medicare could be eligible for coverage of Wegovy now that the blockbuster weight loss drug is also approved in the U. [...]
Weight loss drug patients spend less on restaurants, takeout: survey
A food delivery messenger carries a take out bag outside aSweetgreen in Manhattan on September 14, 2023.Jeenah Moon | The Washington Post | Getty Imag [...]
Eli Lilly’s Zepbound, Mounjaro in short supply through June, FDA says
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023. Brendan McDermid | ReutersMost dos [...]
Eli Lilly weight loss drug Zepbound effective in sleep apnea trials
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023. Brendan McDermid | ReutersEli Lill [...]
Weight loss, diabetes drugs not linked to suicidal thoughts: EU probe
Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. Hollie Adams | ReutersEuropean Union drug regulators fou [...]
Drug similar to Ozempic slowed Parkinson’s disease in small trial
The coronal view of a human brain of a patient suffering from Parkinson's diseaseSherbrooke Connectivity Imaging Lab | Getty ImagesA highly popular cl [...]